Ric Price

Menzies School of Health Research

Registered to supervise postgraduate research

If you made any changes in Pure these will be visible here soon.

Personal profile

Research interests

Professor Ric Price is an infectious disease and general physician on the staff at the Royal Darwin Hospital. He holds a dual academic affiliation as professor of global health at the Menzies School of Health Research and professor of tropical medicine at the Centre of Tropical Medicine, University of Oxford, UK. 

His translational research program focuses on improving the diagnosis and management of multidrug resistant Plasmodium falciparum and Plasmodium vivax infections through a research agenda that spans clinical studies, epidemiology, health economics, pathophysiology, immunology, in vitro studies and molecular biology.
He is currently leading multicentred clinical trials in more than seven malaria endemic countries to optimise the use of primaquine for the radical cure of vivax malaria.
Professor Price chairs the clinical module of the World Wide Antimalarial Resistance Network (WWARN) and the Vivax Working Group of the Asia-Pacific Malaria Elimination Network (APMEN). 

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 18 Similar Profiles
Plasmodium vivax Medicine & Life Sciences
Malaria Medicine & Life Sciences
Plasmodium falciparum Medicine & Life Sciences
Vivax Malaria Medicine & Life Sciences
Falciparum Malaria Medicine & Life Sciences
Antimalarials Medicine & Life Sciences
Chloroquine Medicine & Life Sciences
Parasites Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2003 2019

High risk of Plasmodium vivax malaria following splenectomy in Papua, Indonesia

Kho, S., Andries, B., Commons, R. J., Shanti, PAI., Kenangalem, E., Douglas, N. N., Simpson, J., Sugiarto, P., Anstey, N. & Price, R., 1 Jan 2019, In : Clinical Infectious Diseases. 68, 1, p. 51-60 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
Vivax Malaria
Confidence Intervals
Surgical Instruments

Plasmodium falciparum activates CD16+ dendritic cells to produce TNF and IL-10 in subpatent malaria

Loughland, J. R., Woodberry, T., Boyle, M. J., Tipping, P. E., Piera, K. A., Amante, F. H., Kenangalem, E., Price, R. N., Engwerda, C. R., Anstey, N. M., McCarthy, J. S. & Minigo, G., 29 Jan 2019, In : The Journal of infectious diseases. 219, 4, p. 660-671 12 p., jiy555

Research output: Contribution to journalArticleResearchpeer-review

Open Access
Plasmodium falciparum
Dendritic Cells
Tumor Necrosis Factor-alpha

Risk of Plasmodium vivax parasitaemia after Plasmodium falciparum infection: a systematic review and meta-analysis

Commons, R. J., Simpson, J. A., Thriemer, K., Hossain, M. S., Douglas, N. M., Humphreys, G. S., Sibley, C. H., Guerin, P. J. & Price, R. N., 1 Jan 2019, In : The Lancet Infectious Diseases. 19, 1, p. 91-101 11 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
Plasmodium vivax
Plasmodium falciparum

Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis

Kloprogge, F., Workman, L., Borrmann, S., Tékété, M., Lefèvre, G., Hamed, K., Piola, P., Ursing, J., Kofoed, P. E., Mårtensson, A., Ngasala, B., Björkman, A., Ashton, M., Friberg Hietala, S., Aweeka, F., Parikh, S., Mwai, L., Davis, T. M. E., Karunajeewa, H., Salman, S. & 20 othersChecchi, F., Fogg, C., Newton, P. N., Mayxay, M., Deloron, P., Faucher, J. F., Nosten, F., Ashley, E. A., McGready, R., van Vugt, M., Proux, S., Price, R. N., Karbwang, J., Ezzet, F., Bakshi, R., Stepniewska, K., White, N. J., Guerin, P. J., Barnes, K. I. & Tarning, J., 12 Jun 2018, In : PLoS Medicine. 15, 6, p. 1-27 27 p., e1002579

Research output: Contribution to journalArticleResearchpeer-review

Open Access
Pregnant Women

Artemether-Lumefantrine Versus Chloroquine for the Treatment of Uncomplicated Plasmodium knowlesi Malaria: An Open-Label Randomized Controlled Trial CAN KNOW

Grigg, M., William, T., Barber, B., Rajahram, G. S., Menon, J., Schimann, E., Wilkes, C. S., Patel, K., Chandna, A., Price, R., Yeo, T. & Anstey, N., 15 Jan 2018, In : Clinical Infectious Diseases. 66, 2, p. 229-236 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
Plasmodium knowlesi
Plasmodium malariae
Randomized Controlled Trials